IFRXNasdaq

InflaRx N.V.

Pharmaceutical Preparations · P7 · CIK 1708688

InflaRx N.V. develops and commercializes product candidates, facing risks from product liability lawsuits and cybersecurity incidents

$236M

Market cap

$2.28

Last close

+18.8%

+20.0%

6.8M

Volume

Price · last 39 sessions+7.0%

May 4L $1.60 · H $2.74Jun 29

190

Total filings

May 7, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance